Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease - PubMed (original) (raw)
. 2003 Oct;17(13):1957-9.
doi: 10.1096/fj.03-0203fje. Epub 2003 Aug 15.
Affiliations
- PMID: 12923073
- DOI: 10.1096/fj.03-0203fje
Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease
Hui-Ming Gao et al. FASEB J. 2003 Oct.
Abstract
Parkinson's disease (PD) is a profound movement disorder resulting from progressive degeneration of the nigrostriatal dopaminergic pathway. Although its etiology remains unknown, increasing evidence suggests the involvement of multiple factors such as environmental toxins and genetic susceptibilities in the pathogenesis of PD. In this study using mesencephalic neuron-glia cultures as an in vitro PD model, we demonstrated that the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, 0.1-0.5 microM) and an inflammogen lipopolysaccharide (LPS, 0.5 ng/ml) synergistically induced a progressive and selective degeneration of dopaminergic neurons. The synergistic neurotoxicity was observed when both agents were applied either simultaneously or in tandem. The synergistic neurotoxicity was more prominent when lower doses of both agents were applied for a longer period of time. Mechanistically, microglial NADPH oxidase-mediated generation of reactive oxygen species played a pivotal role in the synergistic neurotoxicity: MPTP and LPS synergistically stimulated the NADPH oxidase-mediated release of superoxide free radical; pharmacological inhibition and genetic inactivation of NADPH oxidase prevented superoxide production and the synergistic neurotoxicity. Additionally, inhibition of nitric oxide synthase afforded significant neuroprotection, suggesting the involvement of nitric oxide in the synergistic neurotoxicity. This study lends strong support for a multifactorial etiology of PD and provides clues for therapeutic interventions.
Similar articles
- Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease.
Gao HM, Liu B, Zhang W, Hong JS. Gao HM, et al. FASEB J. 2003 Oct;17(13):1954-6. doi: 10.1096/fj.03-0109fje. Epub 2003 Aug 1. FASEB J. 2003. PMID: 12897068 - Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease.
Gao HM, Hong JS, Zhang W, Liu B. Gao HM, et al. J Neurosci. 2003 Feb 15;23(4):1228-36. doi: 10.1523/JNEUROSCI.23-04-01228.2003. J Neurosci. 2003. PMID: 12598611 Free PMC article. - Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
Zhang W, Wang T, Qin L, Gao HM, Wilson B, Ali SF, Zhang W, Hong JS, Liu B. Zhang W, et al. FASEB J. 2004 Mar;18(3):589-91. doi: 10.1096/fj.03-0983fje. Epub 2004 Jan 20. FASEB J. 2004. PMID: 14734632 - Nitric oxide and reactive oxygen species in Parkinson's disease.
Tieu K, Ischiropoulos H, Przedborski S. Tieu K, et al. IUBMB Life. 2003 Jun;55(6):329-35. doi: 10.1080/1521654032000114320. IUBMB Life. 2003. PMID: 12938735 Review. - Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
Morale MC, Serra PA, L'episcopo F, Tirolo C, Caniglia S, Testa N, Gennuso F, Giaquinta G, Rocchitta G, Desole MS, Miele E, Marchetti B. Morale MC, et al. Neuroscience. 2006;138(3):869-78. doi: 10.1016/j.neuroscience.2005.07.060. Epub 2005 Dec 5. Neuroscience. 2006. PMID: 16337092 Review.
Cited by
- The complex role of inflammation and gliotransmitters in Parkinson's disease.
Gopinath A, Mackie PM, Phan LT, Tansey MG, Khoshbouei H. Gopinath A, et al. Neurobiol Dis. 2023 Jan;176:105940. doi: 10.1016/j.nbd.2022.105940. Epub 2022 Dec 5. Neurobiol Dis. 2023. PMID: 36470499 Free PMC article. Review. - The mitochondrial ATP-sensitive potassium channel blocker 5-hydroxydecanoate inhibits toxicity of 6-hydroxydopamine on dopaminergic neurons.
Rodriguez-Pallares J, Parga JA, Joglar B, Guerra MJ, Labandeira-Garcia JL. Rodriguez-Pallares J, et al. Neurotox Res. 2009 Jan;15(1):82-95. doi: 10.1007/s12640-009-9010-8. Epub 2009 Feb 24. Neurotox Res. 2009. PMID: 19384591 - Renin angiotensin system and gender differences in dopaminergic degeneration.
Rodriguez-Perez AI, Valenzuela R, Joglar B, Garrido-Gil P, Guerra MJ, Labandeira-Garcia JL. Rodriguez-Perez AI, et al. Mol Neurodegener. 2011 Aug 16;6(1):58. doi: 10.1186/1750-1326-6-58. Mol Neurodegener. 2011. PMID: 21846363 Free PMC article. - Counteracting neuroinflammation in experimental Parkinson's disease favors recovery of function: effects of Er-NPCs administration.
Carelli S, Giallongo T, Gombalova Z, Rey F, Gorio MCF, Mazza M, Di Giulio AM. Carelli S, et al. J Neuroinflammation. 2018 Nov 30;15(1):333. doi: 10.1186/s12974-018-1375-2. J Neuroinflammation. 2018. PMID: 30501635 Free PMC article. - Chronic Systemic Inflammation Exacerbates Neurotoxicity in a Parkinson's Disease Model.
Ugalde-Muñiz P, Fetter-Pruneda I, Navarro L, García E, Chavarría A. Ugalde-Muñiz P, et al. Oxid Med Cell Longev. 2020 Jan 13;2020:4807179. doi: 10.1155/2020/4807179. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32015787 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources